7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.

      1 , , , ,
      Cancer biology & therapy
      Informa UK Limited
      7, 12-dimethylbenzanthracene/12-O-tetradecanoylphorbol-13-acetate, Alb-Cre, Albumin promoter-Cre, CAG promoter, CMV enhancer/chicken β-actin promoter, CAR, chimeric antigen receptor, CIS, common insertion site, CMV, chimeric cytomegalovirus, CRC, colorectal cancer, Cre, cyclization recombination enzyme, DDE, Asp, Asp, Glu, DMBA/TPA, DR, direct orientation, Fah, fumarylacetoacetate hydrolase gene, GWAS, gnome wide analysis study, HBV, Hepatitis B Virus, HBx, HBV X protein, HCC, hepatocellular carcinoma, IRs, inverted repeat sequences, LsL, loxP-stop-loxP, MPNSTs, malignant peripheral nerve sheath tumor, MSCV, murine stem cell virus, PAI, Pro, Ala, Ile, PBMCs, peripheral blood mononuclear cells, RED, Arg, Glu, Asp, RosaSBaseLsL, Cre-inducible SBase allele, Rtl1, Retrotransposon-like 1, SB, Sleeping Beauty, SBase, Sleeping Beauty transposase, Sleeping Beauty transposon system, StatinAE, angiostatin-endostatin fusion gene, Trp53, transformation related protein 53, animal model, driver, gene function, gene therapy, malignant diseases, sgRNA, single guide RNA, shp53, short hairpin RNA against the Trp53 gene, somatic mutation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Carcinogenesis is etiologically associated with somatic mutations of critical genes. Recently, a number of somatic mutations and key molecules have been found to be involved in functional networks affecting cancer progression. Suitable animal models are required to validate cancer-promoting or -inhibiting capacities of these mutants and molecules. Sleeping Beauty transposon system consists of a transposon that carries gene(s) of interest and a transposase that recognizes, excises, and reinserts genes in given location of the genome. It can create both gain-of-function and loss-of-function mutations, thus being frequently chosen to investigate the etiological mechanisms and gene therapy for cancers in animal models. In this review, we summarized current advances of Sleeping Beauty transposon system in revealing molecular mechanism of cancers and improving gene therapy. Understanding molecular mechanisms by which driver mutations contribute to carcinogenesis and metastasis may pave the way for the development of innovative prophylactic and therapeutic strategies against malignant diseases.

          Related collections

          Author and article information

          Journal
          Cancer Biol. Ther.
          Cancer biology & therapy
          Informa UK Limited
          1555-8576
          1538-4047
          2015
          : 16
          : 1
          Affiliations
          [1 ] a Department of Epidemiology ; Second Military Medical University ; Shanghai , China.
          Article
          10.4161/15384047.2014.986944
          4623027
          25455252
          11739379-31c5-4cc3-955c-28dfa990fc5a
          History

          CIS, common insertion site,driver,SBase, Sleeping Beauty transposase,Trp53, transformation related protein 53,animal model,Sleeping Beauty transposon system,somatic mutation,HBV, Hepatitis B Virus,HBx, HBV X protein,Fah, fumarylacetoacetate hydrolase gene,HCC, hepatocellular carcinoma,RED, Arg, Glu, Asp,DR, direct orientation,CAG promoter, CMV enhancer/chicken β-actin promoter,DMBA/TPA,MPNSTs, malignant peripheral nerve sheath tumor,DDE, Asp, Asp, Glu,IRs, inverted repeat sequences,MSCV, murine stem cell virus,RosaSBaseLsL, Cre-inducible SBase allele,SB, Sleeping Beauty,CRC, colorectal cancer,LsL, loxP-stop-loxP,PAI, Pro, Ala, Ile,malignant diseases,StatinAE, angiostatin-endostatin fusion gene,gene therapy,Rtl1, Retrotransposon-like 1,PBMCs, peripheral blood mononuclear cells,GWAS, gnome wide analysis study,CAR, chimeric antigen receptor,Cre, cyclization recombination enzyme,CMV, chimeric cytomegalovirus,shp53, short hairpin RNA against the Trp53 gene,sgRNA, single guide RNA,Alb-Cre, Albumin promoter-Cre,gene function,7, 12-dimethylbenzanthracene/12-O-tetradecanoylphorbol-13-acetate

          Comments

          Comment on this article